Yurogen Biosystems LLC
Yurogen Biosystems LLC is a private biotech company based in the Greater Boston area, a world-class biotech and biopharma hub. We are dedicated to producing premium antibodies and antibody-based products to meet the broad needs of our clients. Along with our traditional polyclonal antibody production, Yurogen is commercializing an innovative platform that can efficiently develop monoclonal antibodies from a variety of host animals especially rabbit. Yurogen is developing a selection of antibodies that are widely used in in vitro diagnostics (IVD) as well as academic research. Our growing list of high-quality antibodies are the reliable and cost-efficient tools that you can count on. Customized antibody services are offered at Yurogen to generate antibodies to meet the needs of our clients. Our state-of-the-art monoclonal antibody screening platform can significantly shorten the antibody screening process and yield high-affinity monoclonal antibodies.
优睿生物科技有限公司（及子公司优睿赛思（武汉）生物科技）的核心技术为基于单个B细胞筛选、培养和克隆技术的全新一代单克隆抗体开发平台（SMab®平台），该技术平台属国内首创、国际领先水平。利用该独特的技术平台，优睿赛思生物科技成功的开发了包括兔单克隆抗体在内的、多种属来源的单克隆抗体，如人、羊驼等。与传统的杂交瘤方法相比，利用SMab®平台可以显著的缩短单克隆抗体开发的周期；优睿赛思生物科技利用改技术平台，在动物免疫完成后能在5周之内获得可测试的重组兔单克隆抗体。兔单克隆抗体以其的高亲和力、高特异性，多样化程度高以及易识别小分子抗原等特点，越来越受到广大科研工作者的青睐。优睿赛思生物科技所开发的兔、羊驼等单克隆抗体产品，被广泛应用于科研、临床诊断和单克隆抗体药物开发等诸多领域。同时，优睿赛思生物科技，竭诚为国内外大型制药公司提供从抗原表达、抗体筛选到抗体人源化的一站式治疗性单克隆抗体开发服务。
